Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic …
G Ntaios, V Papavasileiou, K Makaritsis, K Vemmos… - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Evidence from the real-world setting complements evidence
coming from randomized controlled trials. We aimed to summarize all available evidence …
coming from randomized controlled trials. We aimed to summarize all available evidence …
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran …
Background Stroke is the most serious clinical consequence of atrial fibrillation, which is the
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
Comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants in atrial fibrillation patients
Background and Purpose: Several observational studies have compared the effect of the
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature
Background—Novel oral anticoagulants (NOACs) have been proposed as alternatives to
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
Rivaroxaban versus dabigatran or warfarin in real-world studies of stroke prevention in atrial fibrillation: systematic review and meta-analysis
Y Bai, H Deng, A Shantsila, GYH Lip - Stroke, 2017 - Am Heart Assoc
Background and Purpose—This study was designed to evaluate the effectiveness and
safety of rivaroxaban in real-world practice compared with effectiveness and safety of …
safety of rivaroxaban in real-world practice compared with effectiveness and safety of …
Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: an updated systematic …
G Ntaios, V Papavasileiou, HC Diener… - … Journal of Stroke, 2017 - journals.sagepub.com
Background In a previous systematic review and meta-analysis, we assessed the efficacy
and safety of nonvitamin-K antagonist oral anticoagulants versus warfarin in patients with …
and safety of nonvitamin-K antagonist oral anticoagulants versus warfarin in patients with …
Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
Objective To examine the comparative efficacy and safety of antithrombotic treatments
(apixaban, dabigatran, edoxaban, rivaroxaban and vitamin K antagonists (VKA) at a …
(apixaban, dabigatran, edoxaban, rivaroxaban and vitamin K antagonists (VKA) at a …
Non–vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis
KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - Am Heart Assoc
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Objective To compare the efficacy, safety, and cost effectiveness of direct acting oral
anticoagulants (DOACs) for patients with atrial fibrillation. Design Systematic review …
anticoagulants (DOACs) for patients with atrial fibrillation. Design Systematic review …
相关搜索
- atrial fibrillation meta analysis
- stroke prevention meta analysis
- atrial fibrillation oral anticoagulants
- oral anticoagulants meta analysis
- atrial fibrillation stroke prevention
- atrial fibrillation efficacy and safety
- oral anticoagulants prevention of stroke
- atrial fibrillation setting comparison
- oral anticoagulants setting comparison
- setting comparison meta analysis
- stroke prevention setting comparison
- efficacy and safety meta analysis
- oral anticoagulants warfarin in patients
- stroke prevention efficacy and safety
- atrial fibrillation dabigatran or warfarin
- atrial fibrillation major bleeding